Ketan Desai
Ketan Desai
Send Message
Ketan Desai
Stop FollowingKetan Desai
View Ketan Desai's StockTalks BY TICKER:
-
Ketan Desai
GSK is down pre-market despite a positive panel recommendation. Some concerns about safety in label. Good buying opportunity? - View all 0 replies
-
Ketan Desai
The latest issue of New England Journal of Medicine has a fascinating article on Pfizer's anti-NGF antibody for treatment of osteoarthritis - View all 0 replies
-
Ketan Desai
Arena getting hit today after some FDA questions on its safety and efficacy. Down about 25% - View all 0 replies
